These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17407427)

  • 21. The York Region Methamphetamine Strategy.
    Cronkwright Kirkos W; Carrique T; Griffen K; La Barge AP
    CMAJ; 2008 Jun; 178(13):1655-6. PubMed ID: 18559801
    [No Abstract]   [Full Text] [Related]  

  • 22. The stigmatisation of 'ice' and under-reporting of meth/amphetamine use in general population surveys: A case study from Australia.
    Chalmers J; Lancaster K; Hughes C
    Int J Drug Policy; 2016 Oct; 36():15-24. PubMed ID: 27450550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for treatment-resistive methamphetamine psychosis.
    Fujii D
    J Neuropsychiatry Clin Neurosci; 2002; 14(2):239-40. PubMed ID: 11983802
    [No Abstract]   [Full Text] [Related]  

  • 24. Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study.
    Richards JR; Johnson EB; Stark RW; Derlet RW
    Am J Emerg Med; 1999 Nov; 17(7):681-5. PubMed ID: 10597089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.
    Vearrier D; Greenberg MI; Miller SN; Okaneku JT; Haggerty DA
    Dis Mon; 2012 Feb; 58(2):38-89. PubMed ID: 22251899
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-induced bilateral ischemic infarction in an amphetamine addict.
    Christensen MR; Lesnikova I; Madsen LB; Rosendal I; Banner J
    Forensic Sci Med Pathol; 2013 Sep; 9(3):458-61. PubMed ID: 23504704
    [No Abstract]   [Full Text] [Related]  

  • 27. Methamphetamine psychosis: Lack of association with stimulant prescription ADHD medications.
    Mann DM; Marco CA; Detherage JP; Greene PJ; Ross DE
    Am J Emerg Med; 2019 Sep; 37(9):1802-1803. PubMed ID: 30905477
    [No Abstract]   [Full Text] [Related]  

  • 28. Lower folate levels in methamphetamine-induced psychosis: A cross-sectional study.
    Hadizadeh H; Salehi M; Bozorgnia AR; Ahmadkhaniha HR
    Drug Alcohol Depend; 2020 Feb; 207():107682. PubMed ID: 31841749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Will the methamphetamine problem go away?
    Rawson RA; Anglin MD; Ling W
    J Addict Dis; 2002; 21(1):5-19. PubMed ID: 11831500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methamphetamine--what primary care practitioners need to know.
    McAvoy BR
    J Prim Health Care; 2009 Sep; 1(3):170-6. PubMed ID: 20690379
    [No Abstract]   [Full Text] [Related]  

  • 31. [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
    Härtel-Petri R; Rodler R; Schmeisser U; Steinmann J; Wolfersdorf M
    Psychiatr Prax; 2005 Jan; 32(1):13-7. PubMed ID: 15633070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of risk factors for methamphetamine-associated psychosis.
    Arunogiri S; Foulds JA; McKetin R; Lubman DI
    Aust N Z J Psychiatry; 2018 Jun; 52(6):514-529. PubMed ID: 29338289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants.
    Mahoney JJ; Kalechstein AD; De La Garza R; Newton TF
    Am J Addict; 2008; 17(2):83-98. PubMed ID: 18393050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Spontaneous recrudescence of psychotic diseases caused by methamphetamine (a stimulant): the stress type and the role of noradrenaline and dopamine systems].
    Aburai K; Ikemoto U; Goto K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Oct; 24(5):319-20. PubMed ID: 15658512
    [No Abstract]   [Full Text] [Related]  

  • 35. Meth mouth: methamphetamine and oral health.
    Padilla R; Ritter AV
    J Esthet Restor Dent; 2008; 20(2):148-9. PubMed ID: 18380848
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical Course of Methamphetamine-Induced Psychotic Disorder in a 3-Month Follow-Up.
    Javadian S; Shabani A; Shariat SV
    Prim Care Companion CNS Disord; 2016 Nov; 18(6):. PubMed ID: 27907276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of crystalline methamphetamine ("ice") users and other patients with toxicology-related problems presenting to a hospital emergency department.
    Dargan PI; Wood DM
    Med J Aust; 2008 Aug; 189(4):234. PubMed ID: 18707575
    [No Abstract]   [Full Text] [Related]  

  • 38. Disturbance of consciousness due to methamphetamine abuse. A study of 2 patients.
    Nakatani Y; Hara T
    Psychopathology; 1998; 31(3):131-7. PubMed ID: 9636942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    McKetin R; Baker AL; Dawe S; Voce A; Lubman DI
    Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.